| Literature DB >> 27493928 |
Fereshteh Eftekharizadeh1, Reza Dehnavieh2, Somayeh Noori Hekmat3, Mohammad Hossein Mehrolhassani4.
Abstract
BACKGROUND: Super oxidized water (SOW), as a novel antiseptic solution, is used with claims of effectiveness and cost effectiveness in healing chronic wounds such as diabetic foot, infectious postoperative ulcers and burn ulcers. We conducted a health technology assessment to evaluate the clinical evidence from clinical and randomized trials for this disinfection. This study aims to evaluate the safety, effectiveness and cost-effectiveness of this technology in Iran, for using as a wound disinfectant.Entities:
Keywords: Antiseptic; Betadine; Chronic wound; Cost; Super oxidized water (SOW)
Year: 2016 PMID: 27493928 PMCID: PMC4972067
Source DB: PubMed Journal: Med J Islam Repub Iran ISSN: 1016-1430
Fig. 1
PICO terms
| P | Chronic wound | Diabetic foot, burn ulcer, infectious wound, post-operative wound |
| I | Super oxidized water (SOW) | Dermacyn, Microcyn, Sterilox, Naturasept |
| C | Antiseptics | normal saline, Povidone iodine, hydrogen peroxide |
| O | Effectiveness | Safety and Effect on healing rate, healing time, antibiotic therapy and reduction in infection |
Healing rate
| Author | Year | Healing rate (%) | p | ||
| SOW | PI | ||||
| 1 | Chittoria | 2007 | 40 | - | - |
| 2 | Jesús, Martínez De Fermín, R | 2007 | 90.4 | 31.2 | p=0.001 |
| 3 | PIAGGESI | 2010 | 90 | 55 | p<0.01 |
| 4 | Kapur | 2011 | 70 | 50 | - |
| 5 | SatishKumar | 2013 | 65 | - | - |
Healing time
| Author | Year | Healing rate (%) | p | ||
| SOW | PI | ||||
| 1 | Luca Dalla Paola | 2006 | 6.1 | 7.8 | p<0.0001 |
| 2 | PIAGGESI | 2010 | 10.5 | 16.5 | p=0.007 |
| 3 | Kapur | 2011 | 3 | 3 | - |
| 4 | Aragón Sánchez | 2013 | 6.8 | - | - |
Antibiotic therapy findings
| Author | Year | Healing rate (%) | p | ||
| SOW | PI | ||||
| 1 | Luca Dalla Paola | 2006 | 3-4 | - | |
| 2 | Jesús, Martínez De Fermín, R | 2007 | 3.8 | 4.3 | - |
| 3 | PIAGGESI | 2010 | 10.1 | 15.8 | p=0.16 |
Reduction in Infection
| Author | Year | Healing rate (%) | p | ||
| SOW | PI | ||||
| 1 | Chittoria | 2007 | 95 | - | - |
| 2 | Jesús, Martínez De Fermín, R | 2007 | 80.9 | 43.7 | p=0.01 |
| 3 | SatishKumar | 2013 | 28 | - | - |
Comparison of superoxide water with iodine
| Outcomes | Min-Max | Conclusion | Related articles | |
| SOW | Betadine | |||
| Healing rate | 6.9-65% | 50-62.5% | Sow> betadine | 6 |
| Healing time | 5.1-3 weeks | 5.16-8.7 weeks | Sow> betadine | 4 |
| Antibiotic therapy | 3-1. weeks | 3.4-8.15 weeks | Sow> betadine | 5 |
| Bacterial load | 88-100% reduction | 11-25% reduction | Sow> betadine | 4 |
| Infection control | 9.8-28% | 7.43-28% | Sow> betadine | 4 |
| hospitalization | 4.16-5 days | - | - | 4 |
| Side effects | 0-7 % | 4-7.16% | Sow> betadine | 5 |
Cost Effectiveness results
| Costs criteria | Betadine/500ml | SOW/500ml | Conclusion |
| Direct costs | 132000RL | 255233 RL | Sow< betadine |
| Side effects | With side effect | None | Sow> betadine |
| Equipment need | None | None | Sow= betadine |
| Additional medicines | None | None | Sow= betadine |
| Custom costs | None | None | Sow= betadine |
| transportation | None | 135592 | Sow< betadine |
Data extraction form
| Title | Author | Year | Country | Method | Sample size | Outcomes | Conclusion | |
| 1 | Is ‘Super-Oxidized ‘Water Effective as an Antiseptic in Wound Care? |
| 2009 | Singapore | HTA | 364 | Safety and Effect on Healing e.g. days to re-epithelization, healing rate. Effect on Infection eg bacterial counts, infection rates | SOW is suitable as irrigation and cleansing agent in wound care. Nonetheless, more large-scale studies is necessary to establish the safety, efficacy and cost-effectiveness of ‘Super-Oxidized’ |
| 2 | A randomized controlled trial to examine the efficacy and safety of a new super-oxidized solution for the management of wide postsurgical lesions of the diabetic foot | A. Piaggesi MD et al. | 2010 | Italy | RCT | 40 | healing rate, healing time, time to achieve negative cultures, duration of antibiotic therapy, number of re-interventions, and adverse events | DWC is as safe as and more effective than standard local antiseptics in the management of wide postsurgical lesions in the infected diabetic foot |
| 3 | A randomized controlled trial to examine the efficacy and safety of a new super-oxidized solution for the management of wide postsurgical lesions of the diabetic foot | Fermı´n R Martı´nez-De Jesu´ s et al. | 2007 | Mexico city | RCT | 45 | odor reduction, infection control, Cellulitis reduction | A non-toxic, NpHSS, as part of a comprehensive care regimen, may be more efficacious in infection control, odor and erythema reduction than conventional disinfectants in treatment of diabetic foot infections. |
| 4 | Super-Oxidized Solution (SOS) Therapy for Infected Diabetic Foot Ulcers | Luca Dalla Paola, MD et al | 2006 | Italy | CCT | 218 | reduction in bacterial load from the lesion, healing time, and incidence of skin reactions | SOS is effective and safe in treating infected foot lesions when included within a comprehensive wound care regimen. |
| 5 | Treating infected diabetic wounds with super oxidized water as anti-septic agent: a preliminary experience | Hadi, Syed Fazle et al | 2007 | Pakistan | RCT | 100 | duration of hospital stay, downgrading of the wound category, wound healing time and need for interventions | The results of SOW for the management of infected diabetic wounds are encouraging. Further RCTs are warranted. It may offer an economical alternative to other expensive antiseptics with positive impact on the end points. |
| 6 | Evaluation of effect and comparison of superoxidised solution (oxum) v/s povidone iodine (betadine) | Kapur, Vanita et al | 2011 | India | RCT | 200 | reduction in wound size, edema/erythema, Pus discharge, epithelization |
Oxum treated wounds showed |
| 7 | The role of super oxidized solution in the management of diabetic foot ulcer: our experience | Chittoria, Ravi Kumar et al | 2007 | India | Clinical trial | 20 | Healing rate, infection control, hospitalization days | The moistening effect and minimum toxicity found with the use of this SOW makes it a good choice for diabetic foot ulcer management. However, new controlled trials must be conducted |
| 8 | Superoxidised solution in the management of lower limb ulcers: our experience | SatishKumar, R et al | 2013 | India | Clinical trial | 100 | Wound disinfection, Decrease in wound size, Appearance of Granulation tissue and Duration of Hospital stay | Superoxidised solution is safe and effective in lower limb ulcers, and efficient with significant improvement in appearance of granulation tissue and reduction in duration of hospital stay. |
| 9 | Advanced wound care with stable, super-oxidized water | Wolvos, Tom A | 2006 | Arizona | Clinical Trial | 17 | Toxicity, irrigation, wound disinfection | Dermacyn also appears to be safe to use with tissue-engineered Products and dermal substitutes. Further clinical studies will help confirm the effectiveness and compatibility of Dermacyn in the field of advanced wound care |
| 10 | Super-Oxidized Solution (Dermacyn Wound Care) as Adjuvant Treatment in the Postoperative Management of Complicated Diabetic Foot Osteomyelitis | Aragón-Sánchez, Javier et al | 2013 | Spain | Clinical Trial | 14 |
healing without | Using DWC in the postoperative period of surgery for DFO when the wound is open is safe and may help eradicate the infection when combined with antibiotic treatment. Additional controlled studies are necessary |
| 11 | Superoxidized water improves wound care outcomes in diabetic patients | Bongiovanni, CHERYL M | 2006 | USA |
Case | 8 | bacterial load, healing rate | SOW is effective in reducing bacterial load, enhancing local blood supply, accelerating development of neovascularity and providing a wound environment that is hostile to opportunistic organisms |
| 12 | Mediastinal irrigation with superoxidized water after open-heart surgery: the safety and pitfalls of cardiovascular surgical application | Ohno, Hideaki et al | 2000 | Japan | Clinical Trial | 25 | Anti-bacterial, fungi and anti-viral activity | SOW had no adverse effect on hemodynamic sans was safe when used as a mediastinal irrigation solution during open heart operation via sternotomy |
Outcome results by detail
| Treatment duration | Samples | Average age | Population size | Method | Year | | Article code | ||||||
| Days | Betadine | SOW | | | | ||||||||
| 24 | 20 | 20 | 40 | 61.3 | 62.8 | Infected diabetic foot | RCT | 2010 | Piagesi | ||||
| 20 | 16 | 21 | 45 | 67.8 | 61.9 | Infected diabetic foot | RCT | 2007 | Fermin | ||||
| 24 | 108 | 110 | 218 | 69.6 | Infected diabetic foot | CCT | 2006 | Lucadalla | |||||
| 60 | 50 | 50 | 100 | 40±11 | Diabetic- operative- gangrene ulcer | RCT | 2007 | Hadi | |||||
| 3 | 100 | 100 | 200 | Infected wounds, ulcers, diabetic wounds, abscess, burns | RCT | 2011 | Kapur | ||||||
| 5 day | _ | 20 | 20 | 40-50 | Diabetic foot ulcer | CT | 2007 | Chittoria | |||||
| 21 | 100 | Women=54.65 | men=52.25 | Lower Limb Ulcers/traumatic and diabetic ulcers | CT | 2013 | Satishkumar | ||||||
| 26 | Mixed | CT | 2006 | Wolves | |||||||||
| 14 | Diabetic foot osteomyelitis | CT | 2013 | Aragon | |||||||||
| Outcome criteria | Method | Year | | Article code | |||||||||
| Antibiotic therapy | Healing time | Healing rate | |||||||||||
| Comment | Betadine | SOW | Comment | Betadine | SOW | Comment | Betadine | SOW | | ||||
|
week | 15.8 | 10.1 | P=0.007weeks | 16.5 | 10,5 | X2=9.9P<0.01 | 0.55 | 0.9 | RCT | 2010 | Piagesi | ||
| Week | 4.3 | 3.8 | p=0.001 | 62.5 | 90.4 | RCT | 2007 | Fermin | |||||
| Week | 3 to 4 |
p<0.0001Odd ratio=0.79 | 7.8 | 6.1 | CCT | 2006 | Lucadalla | ||||||
| Percent | 56 | 6 | 3 | 50 | 70 | RCT | 2011 | Kapur | |||||
| 0.4 | CT | 2007 | Chittoria | ||||||||||
| 0.65 | CT | 2013 | Satishkumar | ||||||||||
| Mean | 4.5 | Week | 6.8 | CT | 2013 | Aragon | |||||||
| Outcome criteria | Method | Year | | Article code | |||||||||
| side effects | Hospitalization | Infection control | bacterial load | ||||||||||
| Betadine | SOW | Comment | Comment | Betadine | SOW | Comment | Betadine | SOW | |||||
| e | |||||||||||||
| 11 | 4 | Reduction in bacterial load | 11 | 88 | RCT | 2010 | Piagesi | ||||||
| 0 | 94 | P=0.01 | 43.7 | 80.9 | Percent | 75 | 0 | RCT | 2007 | Fermin | |||
| 16.7 | 0 | Dehiscence after eradication of infection | 19.4 | 12.7 | Strain/median/p=0.0109 | 11.8 | CCT | 2006 | Lucadalla | ||||
| 1 | 50% reduction in comparison to betadine | 50 | Percent/positive culture | 50 | RCT | 2011 | Kapur | ||||||
| Day | 5 | 95 | CT | 2007 | Chittoria | ||||||||
| 56 | day | 16.4 | Percent/in 9 days | 28 | CT | 2013 | Satishkumar | ||||||
| 7 | CT | 2013 | Aragon | ||||||||||